Treatment of pulmonary hypertension: endothelin-receptor antagonists

被引：1
|
作者：
Hoeper, M. M. [1 ]
机构：
[1] Hannover Med Sch, Abtt Pneumol, D-30623 Hannover, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2006年 / 131卷 / 49期
关键词：
D O I：
10.1055/s-2006-957198
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S308 / S310
页数：3
相关论文
共 50 条
  • [1] Endothelin-receptor antagonists in pulmonary hypertension
    Dupuis, J
    [J]. LANCET, 2001, 358 (9288): : 1113 - 1114
  • [2] Endothelin-receptor antagonists in therapy of pulmonary arterial hypertension
    Ghofrani, H. A.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 : S177 - S178
  • [3] HYPERTENSION Endothelin-receptor antagonists for treating hypertension
    Weir, Matthew R.
    [J]. NATURE REVIEWS NEPHROLOGY, 2010, 6 (04) : 192 - 194
  • [4] Endothelin-receptor antagonists for treating hypertension
    Matthew R. Weir
    [J]. Nature Reviews Nephrology, 2010, 6 : 192 - 194
  • [5] Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis
    Aubert, John-David
    Juillerat-Jeanneret, Lucienne
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (18) : 8168 - 8188
  • [6] Endothelin-receptor antagonists in arterial hypertension: Further indications?
    Sudano, Isabella
    Hermann, Matthias
    Ruschitzka, Frank T.
    [J]. CURRENT HYPERTENSION REPORTS, 2007, 9 (01) : 59 - 65
  • [7] Endothelin-receptor antagonists in arterial hypertension: Further indications?
    Isabella Sudano
    Matthias Hermann
    Frank T. Ruschitzka
    [J]. Current Hypertension Reports, 2007, 9
  • [8] Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases
    Marc Humbert
    Gérald Simonneau
    [J]. Nature Clinical Practice Rheumatology, 2005, 1 : 93 - 101
  • [9] Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases
    Humbert, M
    Simonneau, G
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2005, 1 (02): : 93 - 101
  • [10] Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
    Correale, Michele
    Ferraretti, Armando
    Monaco, Ilenia
    Grazioli, Davide
    Di Biase, Matteo
    Brunetti, Natale Daniele
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2018, 14 : 253 - 264
12345